Is Pulmonary Involvement a Distinct Phenotype of Post-COVID-19?

(1) Background: COVID-19 infection often provokes symptoms lasting many months: most commonly fatigue, dyspnea, myalgia and mental distress symptoms. In this study, we searched for clinical features of post-COVID-19 condition (PCC) and differences between patients with and without pulmonary involvement. (2) Methods: A total of 282 patients with a mean age of 57 years (SD +/- 12 years) underwent assessment up to 12 weeks after COVID-19 recovery. The course of acute disease, past medical history and clinical symptoms were gathered; pulmonary function tests were performed; radiographic studies were assessed and follow-up examinations were conducted. Patients with and without detectable pulmonary lesions were divided into separate groups. (3) Results: Patients within the pulmonary group were more often older (59 vs. 51 y.o.; < 0.001) males ( = 0.002) that underwent COVID-19-related hospitalization ( < 0.001) and were either ex- or active smokers with the median of 20 pack-years. We also managed to find correlations with hypertension ( = 0.01), liver failure ( = 0.03), clinical symptoms such as dyspnea ( < 0.001), myalgia ( = 0.04), headache ( = 0.009), sleeplessness ( = 0.046), pulmonary function tests (such as FVC, TLCO, RV and TLC; < 0.001) and several basic laboratory tests (D-dimer, cardiac troponin, WBC, creatinine and others). (4) Conclusions: Our results indicate that initial pulmonary involvement alters the PCC, and it can be used to individualize clinical approaches.